🟢 Syncom Formulations is trading 5.53% up today amid healthcare-sector rally, with no fresh company-specific catalyst

Syncom Formulations is trading 5.53% up at INR 21.18, likely reflecting healthcare-sector rally; no new company-specific announcement was identified for September 2, 2026.

• Q1 FY27 results: consolidated net profit rose 57.7% year over year to ₹24.85 crore; revenue rose 7.3% to ₹125.53 crore.
• Previously announced: ₹0.10 dividend; September 23 record date.
• Shares rose from INR 17.18 on August 24 to INR 21.18, including a 12.23% rise on August 28; sector momentum likely explains it, confidence limited.